---
name: interpreting-fetal-monitoring
language: en
description: Interprets electronic fetal monitoring using NICHD nomenclature with category classification and intervention criteria. Use when reading fetal heart tracings, classifying EFM patterns, or documenting intrapartum monitoring.
tags:
  - analysis
  - obstetrics-and-gynecology
metadata:
  author: casemark
  practice_areas:
    - Obstetrics
    - Gynecology
    - Maternal-Fetal Medicine
  document_types:
    - Interpretation Report
  skill_modes:
    - Analysis
    - Interpretation
---

# Interpreting Fetal Monitoring

Interprets electronic fetal monitoring strips using NICHD nomenclature with three-tier category classification and evidence-based intervention criteria.

## Why This Skill Exists

Electronic fetal monitoring (EFM) is used in over 85% of labors in the United States. The 2008 NICHD consensus established a standardized nomenclature that all obstetric providers must use when interpreting and documenting fetal heart rate (FHR) tracings. Misinterpretation of EFM patterns is one of the most common factors cited in obstetric malpractice claims. Category III tracings require immediate intervention, and delays in recognition can lead to neonatal encephalopathy, cerebral palsy, or death.

This skill enforces the NICHD three-tier system, ensures proper documentation of all EFM components, and maps each category to its required clinical response. Consistent use of this framework reduces inter-observer variability and supports defensible medical records.

---

## Checkpoint A: Pre-Draft Intake (Mandatory)

Before interpreting any EFM tracing, confirm the following:

1. **Gestational age** — Is this a viable fetus (≥ 24 weeks)? Pre-viable tracings are not interpreted by NICHD criteria. (Default: confirm from chart)
2. **Monitoring type** — External Doppler or fetal scalp electrode (FSE)? External tocodynamometer or intrauterine pressure catheter (IUPC)? (Default: external unless stated)
3. **Clinical context** — Latent labor, active labor, second stage, oxytocin augmentation, magnesium sulfate? (Default: note current labor status)
4. **Maternal position** — Supine, lateral, upright? (Default: document if available)
5. **Time window under review** — Specific clock times for the tracing segment being interpreted. (Default: most recent 30-minute window)
6. **Medications administered** — Oxytocin rate, terbutaline, magnesium sulfate, epidural timing? (Default: check MAR)
7. **Prior tracing category** — What was the last documented category? (Default: review prior nursing assessment)

### Documents to Request

- Continuous EFM tracing (digital or paper strip)
- Contraction log or tocodynamometry output
- Nursing labor flowsheet with FHR assessments
- Medication administration record (oxytocin titration log)
- Partogram or cervical exam timeline
- Prior provider tracing interpretations

---

## Step 1: Identify Baseline Fetal Heart Rate

The baseline FHR is the mean rate rounded to increments of 5 bpm during a 10-minute window, excluding accelerations, decelerations, and periods of marked variability.

| Classification | Rate |
|---|---|
| Normal baseline | 110–160 bpm |
| Bradycardia | < 110 bpm for ≥ 10 minutes |
| Tachycardia | > 160 bpm for ≥ 10 minutes |

**Causes of fetal tachycardia:** maternal fever, chorioamnionitis, fetal anemia, maternal hyperthyroidism, beta-agonist administration, fetal tachyarrhythmia.

**Causes of fetal bradycardia:** umbilical cord compression, head compression in second stage, maternal hypothermia, congenital heart block (associated with maternal anti-SSA/Ro antibodies), prolonged cord prolapse.

Document: baseline rate in bpm, duration of observation window, and any inability to determine baseline (e.g., excessive artifact, insufficient tracing time).

---

## Step 2: Assess Variability

Baseline variability reflects the interplay between the sympathetic and parasympathetic nervous systems and is the single most important indicator of fetal acid-base status.

| Classification | Amplitude Range |
|---|---|
| Absent | Undetectable amplitude |
| Minimal | > 0 but ≤ 5 bpm |
| Moderate | 6–25 bpm |
| Marked | > 25 bpm |

**Moderate variability is the most reassuring finding** — its presence, even with decelerations, virtually excludes current fetal metabolic acidemia (pH < 7.00) at the time it is observed.

**Absent variability** combined with recurrent decelerations = Category III (emergency).

Causes of decreased variability (non-pathologic): fetal sleep cycle (typically 20–40 minutes), opioid administration, magnesium sulfate, betamethasone, fetal prematurity.

---

## Step 3: Identify Accelerations and Decelerations

### Accelerations
- **≥ 32 weeks GA:** Peak ≥ 15 bpm above baseline, lasting ≥ 15 seconds
- **< 32 weeks GA:** Peak ≥ 10 bpm above baseline, lasting ≥ 10 seconds
- **Prolonged acceleration:** ≥ 2 minutes but < 10 minutes

### Decelerations

| Type | Onset | Nadir Timing | Mechanism |
|---|---|---|---|
| Early | Gradual onset | Nadir coincides with contraction peak | Head compression (benign) |
| Late | Gradual onset | Nadir occurs after contraction peak | Uteroplacental insufficiency |
| Variable | Abrupt onset (< 30 sec to nadir) | Variable relationship to contraction | Cord compression |
| Prolonged | ≥ 2 min but < 10 min below baseline | — | Multiple etiologies |

**Recurrent** = occurring with ≥ 50% of contractions in a 20-minute window.
**Intermittent** = occurring with < 50% of contractions.

Document each deceleration type, depth (nadir in bpm), duration, and whether recurrent or intermittent.

---

## Step 4: Classify Using the NICHD Three-Tier System

| Category | Criteria | Required Response |
|---|---|---|
| **Category I (Normal)** | Baseline 110–160, moderate variability, no late or variable decels, accelerations may or may not be present, early decels may or may not be present | Continue routine monitoring |
| **Category II (Indeterminate)** | All tracings not meeting Category I or III criteria. Includes: tachycardia, bradycardia not meeting Cat III, minimal variability, absent variability without recurrent decels, marked variability, absence of accelerations after stimulation, recurrent variable decels with minimal/moderate variability, prolonged decel > 2 min but < 10 min, recurrent late decels with moderate variability | Evaluate, continue surveillance, initiate intrauterine resuscitation as indicated, prepare for possible delivery |
| **Category III (Abnormal)** | Absent variability WITH any: recurrent late decels, recurrent variable decels, or bradycardia; OR sinusoidal pattern | Immediate intervention: intrauterine resuscitation, preparation for urgent delivery if no improvement |

---

## Step 5: Document Intrauterine Resuscitation Measures

When Category II or III tracings are identified, document all resuscitation steps:

1. **Maternal repositioning** — left lateral decubitus, right lateral, hands and knees
2. **IV fluid bolus** — 500–1000 mL lactated Ringer's
3. **Oxygen administration** — 10 L/min via non-rebreather (Category III)
4. **Discontinue oxytocin** — if running
5. **Cervical exam** — assess for cord prolapse, rapid cervical change
6. **Tocolysis** — terbutaline 0.25 mg SQ if uterine tachysystole
7. **Amnioinfusion** — if recurrent variable decelerations and ruptured membranes

Document the time each measure was initiated, the tracing response, and the time interval to re-evaluation.

---

## Checkpoint B: Post-Draft Alignment (Mandatory)

Before finalizing any EFM interpretation document:

1. **Are all five NICHD components documented** — baseline, variability, accelerations, decelerations, and uterine activity?
2. **Is the category classification explicitly stated** (I, II, or III)?
3. **Does the documented clinical response match the category** — i.e., Category III has immediate intervention documented?
4. **Is the contraction pattern documented** — frequency, duration, and presence/absence of tachysystole (> 5 contractions in 10 minutes)?
5. **Are time stamps included** for tracing windows, category changes, and interventions?

---

## Quality Audit

- [ ] Baseline FHR is stated in bpm with the observation window
- [ ] Variability is classified using the four-tier NICHD system (absent, minimal, moderate, marked)
- [ ] Accelerations are documented with criteria appropriate for gestational age
- [ ] All deceleration types are named (early, late, variable, prolonged) with depth and duration
- [ ] Recurrent vs. intermittent classification is stated for decelerations
- [ ] NICHD category (I, II, or III) is explicitly assigned
- [ ] Uterine activity is documented (contraction frequency, duration, tachysystole present/absent)
- [ ] Sinusoidal pattern is specifically ruled in or out when variability is absent
- [ ] Clinical response is documented and matches the category classification
- [ ] Time of interpretation and interpreting provider are recorded
- [ ] Monitoring type (external vs. internal) is specified
- [ ] Maternal vital signs at time of interpretation are included
- [ ] Communication with attending physician is documented for Category II/III tracings
- [ ] Tracing artifact or signal loss is noted if present

---

## Guidelines

1. **Use only NICHD terminology** — never use legacy terms such as "fetal distress," "reassuring," or "non-reassuring." Use "Category I/II/III" and specific descriptors.
2. **Moderate variability is the key finding** — its presence is the strongest predictor of normal fetal acid-base status at the time observed.
3. **Category II is a broad bucket** — always specify which features place the tracing in Category II and document the surveillance plan.
4. **Interpret in context** — a transient bradycardia during pushing with rapid recovery is different from sustained bradycardia at 4 cm dilation.
5. **Document the contraction pattern** — tachysystole (> 5 contractions/10 min averaged over 30 min) is an independent risk factor regardless of FHR category.
6. **Never interpret a tracing in isolation** — correlate with maternal status, labor progress, and medications.
7. **Time-stamp everything** — medicolegal defensibility depends on documented timeline of recognition, communication, and action.
8. **When in doubt, escalate** — document that attending was notified and present for evaluation of Category II or III tracings.